Search for a doctor

Brad S. Hoppe, M.D., M.P.H.

  1. Radiation Oncologist
Request an Appointment

Publications

  1. Gao RW, Fleuranvil RF, Harmsen WS, Tao R, Pulsipher SD, Greipp PT, Baughn LB, Jevremovic D, Gonsalves WI, Kourelis TV, Stish BJ, Peterson JL, Rule WG, Hoppe BS, Breen WG, Lester SC. Predictors of Local Control With Palliative Radiotherapy for Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2025 Mar; 25 (3):212-218 Epub 2024 Oct 05
    View PubMed
  2. Daw S, Cole PD, Hoppe BS, Hodgson D, Beishuizen A, Garnier N, Buffardi S, Mascarin M, Lissat A, Mauz-Korholz C, Krajewski J, Akyol A, Crowe R, Anderson B, Xu Y, Drachtman RA, Kelly KM, Leblanc T, Harker-Murray P. Transplant-Free Approach in Relapsed Hodgkin Lymphoma in Children, Adolescents, and Young Adults: A Nonrandomized Clinical Trial. JAMA Oncol. 2025 Jan 2 Epub 2025 Jan 02
    View PubMed
  3. Hoppe BS, Milgrom SA, Renfro LA, Wu Y, Schwartz CL, Constine LS, McCarten KM, Kelly KM, Hodgson D, Castellino SM, Keller FG. Transplant-Free Salvage Therapy for Low-Risk Relapsed Pediatric Hodgkin Lymphoma: A Nonrandomized Clinical Trial. JAMA Oncol. 2025 Jan 2 Epub 2025 Jan 02
    View PubMed
  4. Stoevesandt D, Steglich J, Bartelt JM, Kurch L, McCarten KM, Flerlage JE, Georgi TW, Mauz-Korholz C, Cho SY, Korholz D, Kluge R, Kelly KM, Pelz T, Vordermark D, Hoppe BS, Dieckmann K, Voss SD. CT, MRI, and FDG PET/CT in the Assessment of Lymph Node Involvement in Pediatric Hodgkin Lymphoma: An Expert Consensus Definition by an International Collaboration on Staging Evaluation and Response Criteria Harmonization for Children, Adolescent, and Young Adult Hodgkin Lymphoma (SEARCH for CAYAHL). Radiology. 2025 Jan; 314 (1):e232650
    View PubMed
  5. Saifi O, Pinnix CC, Ballas LK, Kelsey CR, Milgrom SA, Terezakis SA, Figura NB, Parikh RR, Grecula JC, Flampouri S, Ha CS, Lo AC, Plastaras JP, Hodgson DC, Hoppe BS. Radiation target nomenclature for lymphoma trials: consensus recommendations from the National Clinical Trials Network groups. Lancet Haematol. 2024 Dec; 11 (12):e951-e958 Epub 2024 Sept 30
    View PubMed
  6. Saifi O, Breen WG, Lester SC, Rule WG, Stish BJ, Rosenthal A, Munoz J, Lin Y, Bansal R, Hathcock MA, Johnston PB, Ansell SM, Paludo J, Khurana A, Villasboas JC, Wang Y, Iqbal M, Alhaj Moustafa M, Murthy HS, Ayala E, Kharfan-Dabaja MA, Hoppe BS, Peterson JL. Outcomes of patients with R/R B-cell NHL and limited (<5 sites) pre-CART disease bridged with or without radiotherapy. Blood Adv. 2024 Sep 24; 8 (18):4877-4885
    View PubMed
  7. Saifi O, Hoppe BS. Contemporary radiation therapy use in Hodgkin lymphoma. Semin Hematol. 2024 Aug; 61 (4):263-269 Epub 2024 May 31
    View PubMed
  8. Binkley MS, Flerlage JE, Savage KJ, Akhtar S, Steiner R, Zhang XY, Dickinson M, Prica A, Major A, Hendrickson PG, Hopkins D, Ng A, Casulo C, Baron J, Roberts KB, Al Kendi J, Balogh A, Ricardi U, Torka P, Specht L, De Silva R, Pickard K, Blazin LJ, Henry M, Smith CM, Halperin D, Brady J, Brennan B, Senchenko MA, Reeves M, Hoppe BS, Terezakis S, Talaulikar D, Picardi M, Kirova Y, Fergusson P, Hawkes EA, Lee D, Doo NW, Barraclough A, Cheah CY, Ku M, Hamad N, Mutsando H, Gilbertson M, Marconi T, Viiala N, Maurer MJ, Eichenauer DA, Hoppe RT, GLOW Consortium. International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin Lymphoma. J Clin Oncol. 2024 Jul 1; 42 (19):2271-2280 Epub 2024 Mar 26
    View PubMed
  9. Laughlin BS, Van Der Walt C, Mangold AR, Breen WG, Rosenthal AC, Lester S, Hoppe B, Peterson J, Bogan A, Rule WG. Fine-Tuning Low-Dose Total Skin Electron Therapy for Optimal Management of Cutaneous T-Cell Lymphoma: A Comparative Analysis of Regimens. Adv Radiat Oncol. 2024 Jul; 9 (7):101502 Epub 2024 Mar 24
    View PubMed
  10. Baliga S, Patel S, Naqa IE, Li XA, Cohen LE, Howell RM, Hoppe BS, Constine LS, Palmer JD, Hamstra D, Olch AJ. Testicular Dysfunction in Male Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review. Int J Radiat Oncol Biol Phys. 2024 Jun 1; 119 (2):610-624 Epub 2023 Oct 03
    View PubMed
  11. Laughlin BS, Zaniletti I, Foster MG, Lucido J, Mangold AR, Rosenthal AC, VAN DER Walt C, Breen W, Lester S, Hoppe B, Petersen J, Armstrong MD, Bogan A, Rule WG. Tailoring Radiation Therapy for Patients With Limited Cutaneous T Cell Lymphoma: Preliminary Clinical Experience With Subtotal Skin Electron Therapy. Anticancer Res. 2024 Apr; 44 (4):1491-1497
    View PubMed
  12. Wisdom AJ, Barker CA, Chang JY, Demaria S, Formenti S, Grassberger C, Gregucci F, Hoppe BS, Kirsch DG, Marciscano AE, Mayadev J, Mouw KW, Palta M, Wu CC, Jabbour SK, Schoenfeld JD. The Next Chapter in Immunotherapy and Radiation Combination Therapy: Cancer-Specific Perspectives. Int J Radiat Oncol Biol Phys. 2024 Apr 1; 118 (5):1404-1421 Epub 2024 Jan 05
    View PubMed
  13. Burlile JF, Frechette KM, Breen WG, Hwang SR, Higgins AS, Nedved AN, Harmsen WS, Pulsipher SD, Witzig TE, Micallef IN, Hoppe BS, Habermann TM, Thanarajasingam G, Johnston PB, Inwards DJ, Bennani NN, Peterson JL, Stish BJ, Rule WG, Ansell SM, Lester SC. Patterns of progression after immune checkpoint inhibitors for Hodgkin lymphoma: implications for radiation therapy. Blood Adv. 2024 Mar 12; 8 (5):1250-1257
    View PubMed
  14. Bush A, Herchko S, Chellini A, Orande C, Harrell A, Wear M, Rutenberg M, Attia A, Trifiletti D, Peterson J, May B, Vallow L, Hoppe B. Prompt Pain Relief From Bone Metastases: The Virtual Simulation Program. Adv Radiat Oncol. 2024 Feb; 9 (2):101361 Epub 2023 Aug 25
    View PubMed
  15. Saifi O, Lester SC, Breen WG, Rule WG, Lin Y, Bennani NN, Rosenthal A, Munoz J, Murthy HS, Kharfan-Dabaja MA, Peterson JL, Hoppe BS. Incorporating radiation with anti-CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory non-Hodgkin lymphoma: A multicenter consensus approach. Am J Hematol. 2024 Jan; 99 (1):124-134 Epub 2023 Nov 11
    View PubMed
  16. Saifi O, Breen WG, Lester SC, Rule WG, Stish BJ, Rosenthal A, Munoz J, Lin Y, Bansal R, Hathcock MA, Johnston PB, Ansell SM, Paludo J, Khurana A, Villasboas JC, Wang Y, Iqbal M, Moustafa MA, Murthy HS, Kharfan-Dabaja MA, Peterson JL, Hoppe BS. Consolidative radiotherapy for residual fluorodeoxyglucose activity on day +30 post CAR T-cell therapy in non-Hodgkin lymphoma. Haematologica. 2023 Nov 01; 108(11):2982-2992.
    View PubMed
  17. Holtzman AL, Seidensaal K, Iannalfi A, Kim KH, Koto M, Yang WC, Shiau CY, Mahajan A, Ahmed SK, Trifiletti DM, Peterson JL, Koffler DM, Vallow LA, Hoppe BS, Rutenberg MS. Carbon Ion Radiotherapy: An Evidence-Based Review and Summary Recommendations of Clinical Outcomes for Skull-Base Chordomas and Chondrosarcomas. Cancers (Basel). 2023 Oct 17; 15 (20)
    View PubMed
  18. Mailhot Vega RB, Harker-Murray PD, Forlenza CJ, Cole P, Kelly KM, Milgrom SA, Parikh RR, Hodgson DC, Castellino SM, Kahn J, Roberts KB, Constine LS, Hoppe BS. Radiation Therapy Use in Refractory and Relapsed Adolescent and Young Adult Hodgkin Lymphoma: A Report from the Children's Oncology Group. Int J Radiat Oncol Biol Phys. 2023 Oct 1; 117 (2):400-403 Epub 2023 Apr 26
    View PubMed
  19. Ahern V, Adeberg S, Fossati P, Garrett R, Hoppe B, Mahajan A, Orlandi E, Orecchia R, Prokopovich D, Seuntjens J, Thwaites D, Trifiletti D, Tsang R, Tsuji H. An international approach to estimating the indications and number of eligible patients for carbon ion radiation therapy (CIRT) in Australia. Radiother Oncol. 2023 Oct; 187:109816 Epub 2023 July 20
    View PubMed
  20. Castellino SM, Giulino-Roth L, Harker-Murray P, Kahn JM, Forlenza C, Cho S, Hoppe B, Parsons SK, Kelly KM, COG Hodgkin Lymphoma Committee. Children's Oncology Group's 2023 blueprint for research: Hodgkin lymphoma. Pediatr Blood Cancer. 2023 Sep; 70 Suppl 6 (Suppl 6):e30580 Epub 2023 July 28
    View PubMed
  21. Kalapurakal JA, Wolden SL, Haas-Kogan D, Laack NN, Hua CH, Paulino AC, Hill-Kayser CE, Hoppe BS, Fitzgerald TJ, COG Radiation Oncology Discipline Committee. Children's Oncology Group's 2023 blueprint for research: Radiation oncology. Pediatr Blood Cancer. 2023 Sep; 70 Suppl 6 (Suppl 6):e30593 Epub 2023 July 24
    View PubMed
  22. Bates JE, Shrestha S, Liu Q, Smith SA, Mulrooney DA, Leisenring W, Gibson T, Robison LL, Chow EJ, Oeffinger KC, Armstrong GT, Constine LS, Hoppe BS, Lee C, Yasui Y, Howell RM. Cardiac Substructure Radiation Dose and Risk of Late Cardiac Disease in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. J Clin Oncol. 2023 Aug 1; 41 (22):3826-3838 Epub 2023 June 12
    View PubMed
  23. Lo AC, Lee I, Pei Q, Wu Y, McCarten KM, Hoppe BS, Hodgson DC, Roberts K, Milgrom S, Kessel S, Cole PD, Kelly KM, Cho SY. Prognostic value of chest x-ray- and CT-defined large mediastinal adenopathy in high-risk pediatric Hodgkin lymphoma: A report from the Children's Oncology Group Study AHOD0831. Pediatr Blood Cancer. 2023 Aug; 70 (8):e30452 Epub 2023 May 27
    View PubMed
  24. Hoppe BS, McCarten KM, Pei Q, Kessel S, Alazraki A, Mhlanga JC, Lai HA, Eutsler E, Hodgson DC, Roberts KB, Charpentier AM, Keller FG, Voss SD, Wu Y, Cho SY, Kelly KM, Castellino SM. Importance of Central Imaging Review in a Pediatric Hodgkin Lymphoma Trial Using Positron Emission Tomography Response Adapted Radiation Therapy. Int J Radiat Oncol Biol Phys. 2023 Aug 1; 116 (5):1025-1030 Epub 2023 Mar 02
    View PubMed
  25. Saifi O, Breen WG, Lester SC, Rule WG, Stish BJ, Rosenthal A, Munoz J, Lin Y, Bansal R, Hathcock MA, Bennani NN, Paludo J, Khurana A, Villasboas JC, Johnston PB, Ansell SM, Iqbal M, Moustafa MA, Murthy HS, Kharfan-Dabaja MA, Hoppe BS, Peterson JL. Don't Put the CART Before the Horse: The Role of Radiation Therapy in Peri-CAR T-cell Therapy for Aggressive B-cell Non-Hodgkin Lymphoma. Int J Radiat Oncol Biol Phys. 2023 Aug 1; 116 (5):999-1007 Epub 2022 Dec 21
    View PubMed
  26. Chohan KL, Young JR, Lester S, Moustafa MA, Rosenthal A, Tun HW, Hoppe BS, Johnston PB, Micallef IN, Habermann TM, Ansell SM. End-of-treatment PET in early-stage Hodgkin lymphoma: valuable in addition to interim PET. Haematologica 2023 Jun 1; 108 (6):1697-1701 Epub 2023 June 01
    View PubMed
  27. Milgrom SA, Kim J, Pei Q, Lee I, Hoppe BS, Wu Y, Hodgson D, Kessel S, McCarten KM, Roberts K, Lo AC, Cole PD, Kelly KM, Cho SY. Baseline metabolic tumour burden improves risk stratification in Hodgkin lymphoma: A Children's Oncology Group study. Br J Haematol. 2023 Jun; 201 (6):1192-1199 Epub 2023 Mar 15
    View PubMed
  28. Casey D, McCarten K, Pei Q, Milgrom S, Belsky J, Cho S, Keller F, Punnett A, Hoppe B, Kelly K, Castellino S. 17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023. Hematol Oncol. 2023 Jun; 41 Suppl 2:69
    View PubMed
  29. Harker-Murray P, Mauz-Korholz C, Leblanc T, Mascarin M, Michel G, Cooper S, Beishuizen A, Leger KJ, Amoroso L, Buffardi S, Rigaud C, Hoppe BS, Lisano J, Francis S, Sacchi M, Cole PD, Drachtman RA, Kelly KM, Daw S. Nivolumab and brentuximab vedotin with or without bendamustine for R/R Hodgkin lymphoma in children, adolescents, and young adults. Blood. 2023 Apr 27; 141 (17):2075-2084
    View PubMed
  30. Alhaj Moustafa M, Borah BJ, Moriarty JP, Dholakia R, Jiang L, Li K, Witzig TE, Hoppe BS, Peterson J, Cerhan JR, Tun HW. Yttrium-90 Ibritumomab Tiuxetan is Cost-Effective Compared to Bendamustine + Rituximab in Low-grade Lymphomas. Clin Lymphoma Myeloma Leuk. 2023 Apr; 23 (4):259-265 Epub 2023 Jan 26
    View PubMed
  31. Hoppe BS, Petersen IA, Wilke BK, DeWees TA, Imai R, Hug EB, Fiore MR, Debus J, Fossati P, Yamada S, Orlandi E, Zhang Q, Bao C, Seidensaal K, May BC, Harrell AC, Houdek MT, Vallow LA, Rose PS, Haddock MG, Ashman JB, Goulding KA, Attia S, Krishnan S, Mahajan A, Foote RL, Laack NN, Keole SR, Beltran CJ, Welch EM, Karim M, Ahmed SK. Pragmatic, Prospective Comparative Effectiveness Trial of Carbon Ion Therapy, Surgery, and Proton Therapy for the Management of Pelvic Sarcomas (Soft Tissue/Bone) Involving the Bone: The PROSPER Study Rationale and Design. Cancers (Basel). 2023 Mar 8; 15 (6) Epub 2023 Mar 08
    View PubMed
  32. Tun AJ, Hoppe BS, Zhao Y, Makey I, Fernandez-Bussy S, Liang X. Radiation Therapy for Primary Adenoid Cystic Carcinoma of the Trachea: Photons, Protons, or Carbon. Int J Part Ther. 2023 Spring; 9 (4):302-305 Epub 2023 Jan 12
    View PubMed
  33. Kahn JM, Yang JC, Yahalom J, Dabaja BS, Vapiwala N, Hoppe BS, Tseng YD, Pinnix CC, Parikh RR, Sim AJ, Plastaras JP, Gunther JR, with the ILROG Educational Steering Committee, ARRO Executive Committee. Assessment of Lymphoma and Other Hematologic Malignancies Training Needs Among Radiation Oncology Residents: a Brief Report. J Cancer Educ. 2023 Feb; 38 (1):201-205 Epub 2021 Oct 02
    View PubMed
  34. Baron JA, Wright CM, Maxwell R, Kim MM, Giap F, Vega RBM, Hoppe BS, LaRiviere MJ, Maity A, Plastaras JP, Paydar I. Proton Radiation Therapy After Chemotherapy in the Management of Aggressive Mediastinal Non-Hodgkin Lymphomas: A Particle Therapy Cooperative Group Lymphoma Subcommittee Collaboration. Adv Radiat Oncol. 2023 Jan-Feb; 8 (1):101090 Epub 2022 Oct 03
    View PubMed
  35. Casey D, McCarten K, Pei Q, Milgrom S, Belsky J, Cho S, Keller F, Punnett A, Hoppe B, Kelly K, Castellino S. Patterns of presentation and outcomes in stage iv Hodgkin lymphoma; a report from the Children's Oncology Group (COG) ahod1331 Trial. Hematological Oncology. 2023; 41 (S2):69
  36. Saifi O, Hoppe BS. Radiation Therapy in Diffuse Large B-cell Lymphoma: A Little Boost gets you over the Finish Line Oncology. 2022; 36(12):722-723.
  37. Bates JE, Terezakis S, Morris CG, Rao AD, Sehgal S, Kumar R, Mailhot Vega RB, Mendenhall NP, Hoppe BS. Comparative Effectiveness of Proton Therapy versus Photon Radiotherapy in Adolescents and Young Adults for Classical Hodgkin Lymphoma. Int J Part Ther. 2022 Winter; 8 (3):21-27 Epub 2021 July 08
    View PubMed
  38. Rutenberg MS, Hoppe BS, Starr JS, Awad Z, Thomas M, Morris CG, Johnson P, Henderson RH, Jones JC, Gharia B, Bowers S, Wolfsen HC, Krishnan S, Ko SJ, Babiker HM, Nichols RC Jr. Proton Therapy With Concurrent Chemotherapy for Thoracic Esophageal Cancer: Toxicity, Disease Control, and Survival Outcomes. Int J Part Ther. 2023 Winter; 9 (3):18-29 Epub 2022 Dec 19
    View PubMed
  39. Patel CG, Peterson J, Aznar M, Tseng YD, Lester S, Pafundi D, Flampouri S, Mohindra P, Parikh RR, Mailhot Vega R, Konig L, Plastaras JP, Bates JE, Loap P, Kirova YM, Orlandi E, Lutgendorf-Caucig C, Ntentas G, Hoppe B. Systematic review for deep inspiration breath hold in proton therapy for mediastinal lymphoma: A PTCOG Lymphoma Subcommittee report and recommendations. Radiother Oncol. 2022 Dec; 177:21-32 Epub 2022 Oct 14
    View PubMed
  40. Castellino SM, Pei Q, Parsons SK, Hodgson D, McCarten K, Horton T, Cho S, Wu Y, Punnett A, Dave H, Henderson TO, Hoppe BS, Charpentier AM, Keller FG, Kelly KM. Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin's Lymphoma. N Engl J Med. 2022 Nov 3; 387 (18):1649-1660
    View PubMed
  41. Parekh A, Keller FG, McCarten KM, Kessel S, Cho S, Pei Q, Wu Y, Castellino SM, Constine LS, Schwartz CL, Hodgson D, Kelly KM, Hoppe BS. Targeted radiotherapy for early-stage, low-risk pediatric Hodgkin lymphoma slow early responders: a COG AHOD0431 analysis. Blood. 2022 Sep 8; 140 (10):1086-1093
    View PubMed
  42. Gao RW, Day CN, Yu NY, Bush A, Amundson AC, Prodduturvar P, Majeed U, Butts E, Oliver T, Schwecke AJ, Moffett JN, Routman DM, Breen WG, Potter AL, Rivera-Concepcion J, Hoppe BS, Schild SE, Sio TT, Lou Y, Ernani V, Ko S, Olivier KR, Merrell KW, Garces YI, Manochakian R, Harmsen WS, Leventakos K, Owen D. Dosimetric predictors of pneumonitis in locally advanced non-small cell lung cancer patients treated with chemoradiation followed by durvalumab. Lung Cancer. 2022 Aug; 170:58-64 Epub 2022 June 13
    View PubMed
  43. Alhaj Moustafa M, Peterson J, Hoppe BS, Jiang J, Wiseman GA, Witzig TE, Tun HW. Real World Long-term Follow-up Experience with Yttrium-90 ibritumomab tiuxetan in Previously Untreated Patients with Low-Grade Follicular Lymphoma and Marginal Zone Lymphoma. Clin Lymphoma Myeloma Leuk. 2022 Aug; 22 (8):618-625 Epub 2022 Mar 17
    View PubMed
  44. Chohan KL, Young JR, Lester S, Alhaj Moustafa M, Rosenthal A, Tun HW, Hoppe BS, Johnston PB, Micallef IN, Habermann TM, Ansell SM. A real-world study of combined modality therapy for early-stage Hodgkin lymphoma: too little treatment impacts outcome. Blood Adv. 2022 Jul 26; 6 (14):4241-4250
    View PubMed
  45. Hoppe BS, Nichols RC, Flampouri S, Pankuch M, Morris CG, Pham DC, Mohindra P, Hartsell WF, Mohammed N, Chon BH, Kestin LL, Simone CB 2nd. Chemoradiation with Hypofractionated Proton Therapy in Stage II-III Non-Small Cell Lung Cancer: A Proton Collaborative Group Phase 2 Trial. Int J Radiat Oncol Biol Phys. 2022 Jul 15; 113 (4):732-741 Epub 2022 Mar 17
    View PubMed
  46. Henderson RH, Bryant CM, Nichols RC, Mendenhall WM, Hoppe BS, Su Z, Morris CG, Mendenhall NP. Five- and seven-year outcomes for image-guided moderately accelerated hypofractionated proton therapy for prostate cancer. Acta Oncol. 2022 Apr; 61 (4):468-477 Epub 2021 Dec 30
    View PubMed
  47. Parikh RR, Kelly KM, Hodgson DC, Hoppe BS, McCarten KM, Karolczuk K, Pei Q, Wu Y, Cho SY, Schwartz C, Cole PD, Roberts K. Patterns of Initial Relapse from a Phase 3 Study of Response-Based Therapy for High-Risk Hodgkin Lymphoma (AHOD0831): A Report from the Children's Oncology Group. Int J Radiat Oncol Biol Phys. 2022 Mar 15; 112 (4):890-900 Epub 2021 Nov 09
    View PubMed
  48. Butala AA, Huang CC, Bryant CM, Henderson RH, Hoppe BS, Mendenhall NP, Vapiwala N, Mailhot Vega RB. Heterogeneity in Radiotherapeutic Parameter Assumptions in Cost-Effectiveness Analyses in Prostate Cancer: A Call for Uniformity. Value Health. 2022 Feb; 25 (2):171-177 Epub 2021 Oct 22
    View PubMed
  49. Hall MD, Terezakis SA, Lucas JT, Gallop-Evans E, Dieckmann K, Constine LS, Hodgson D, Flerlage JE, Metzger ML, Hoppe BS. Radiation Therapy Across Pediatric Hodgkin Lymphoma Research Group Protocols: A Report From the Staging, Evaluation, and Response Criteria Harmonization (SEARCH) for Childhood, Adolescent, and Young Adult Hodgkin Lymphoma (CAYAHL) Group. Int J Radiat Oncol Biol Phys. 2022 Feb 1; 112 (2):317-334 Epub 2021 Aug 12
    View PubMed
  50. Saifi O, Breen WG, Lester SC, Rule WG, Stish B, Rosenthal A, Munoz J, Herchko SM, Murthy HS, Lin Y, Bansal R, Hathcock MA, Bennani NN, Paludo J, Wang Y, Khurana A, Bisneto JCV, Johnston PB, Ansell SM, Iqbal M, Tun H, Ayala E, Kharfan-Dabaja MA, Hoppe BS, Peterson JL. Does bridging radiation therapy affect the pattern of failure after CAR T-cell therapy in non-Hodgkin lymphoma? Radiother Oncol. 2022 Jan; 166:171-179. Epub 2021 Dec 07.
    View PubMed
  51. Mailhot Vega RB, Mohammadi H, Patel SI, Holtzman AL, Lockney NA, Lynch JW, Bansal MM, Liang X, Slayton WB, Parsons SK, Hoppe BS, Mendenhall NP. Establishing Cost-Effective Allocation of Proton Therapy for Patients With Mediastinal Hodgkin Lymphoma. Int J Radiat Oncol Biol Phys. 2022 Jan 01; 112(1):158-166. Epub 2021 Aug 02.
    View PubMed
  52. Parekh AD, Indelicato DJ, Hoppe BS, Vega RBM, Rotondo RL, Bradley JA. Pulmonary dose tolerance in hemithorax radiotherapy for Ewing sarcoma of the chest wall: Are we overestimating the risk of radiation pneumonitis? Pediatr Blood Cancer. 2021 Nov; 68 (11):e29287 Epub 2021 Aug 16
    View PubMed
  53. Mendenhall NP, Rausch Osian SM, Bryant CM, Hoppe BS, Morris CG. What men want: Results from a national survey on decision making for prostate cancer treatment and research participation. Clin Transl Sci. 2021 Nov; 14 (6):2314-2326 Epub 2021 Aug 11
    View PubMed
  54. Shrestha S, Bates JE, Liu Q, Smith SA, Oeffinger KC, Chow EJ, Gupta AC, Owens CA, Constine LS, Hoppe BS, Leisenring WM, Qiao Y, Weathers RE, Court LE, Pinnix CC, Kry SF, Mulrooney DA, Armstrong GT, Yasui Y, Howell RM. Radiation therapy related cardiac disease risk in childhood cancer survivors: Updated dosimetry analysis from the Childhood Cancer Survivor Study. Radiother Oncol. 2021 Oct; 163:199-208 Epub 2021 Aug 26
    View PubMed
  55. Bryant CM, Henderson RH, Nichols RC, Mendenhall WM, Hoppe BS, Vargas CE, Daniels TB, Choo CR, Parikh RR, Giap H, Slater JD, Vapiwala N, Barrett W, Nanda A, Mishra MV, Choi S, Liao JJ, Mendenhall NP, Genitourinary Subcommittee of the Particle Therapy Co-Operative Group. Consensus Statement on Proton Therapy for Prostate Cancer. Int J Part Ther. 2021 Fall; 8 (2):1-16 Epub 2021 Apr 12
    View PubMed
  56. Milgrom SA, Kim J, Chirindel A, Kim J, Pei Q, Chen L, Buxton A, Kessel S, Leal J, McCarten KM, Hoppe BS, Wolden SL, Schwartz CL, Friedman DL, Kelly KM, Cho SY. Prognostic value of baseline metabolic tumor volume in children and adolescents with intermediate-risk Hodgkin lymphoma treated with chemo-radiation therapy: FDG-PET parameter analysis in a subgroup from COG AHOD0031. Pediatr Blood Cancer. 2021 Sep; 68 (9):e29212 Epub 2021 July 10
    View PubMed
  57. Hoppe BS, Advani R, Milgrom SA, Bakst RL, Ballas LK, Dabaja BS, Flowers CR, Ha CS, Mansur DB, Metzger ML, Pinnix CC, Plastaras JP, Roberts KB, Smith SM, Terezakis SA, Kirwan JM, Constine LS. Primary Mediastinal B Cell Lymphoma in the Positron-Emission Tomography Era Executive Summary of the American Radium Society Appropriate Use Criteria. Int J Radiat Oncol Biol Phys. 2021 Sep 1; 111 (1):36-44 Epub 2021 Mar 24
    View PubMed
  58. Indelicato DJ, Bates JE, Mailhot Vega RB, Rotondo RL, Hoppe BS, Morris CG, Looi WS, Sandler ES, Aldana PR, Bradley JA. Second tumor risk in children treated with proton therapy. Pediatr Blood Cancer. 2021 Jul; 68 (7):e28941 Epub 2021 Feb 09
    View PubMed
  59. Saifi O, Lester SC, Rule W, Stish BJ, Stafford S, Pafundi DH, Jiang L, Menke D, Moustafa MA, Rosenthal A, Sher T, Ernesto A, Tun HW, Hoppe BS, Peterson JL. Comparable Efficacy of Reduced Dose Radiation Therapy for the Treatment of Early Stage Gastric Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue. Adv Radiat Oncol. 2021 Jul-Aug; 6 (4):100714 Epub 2021 May 08
    View PubMed
  60. Flerlage JE, Hiniker SM, Armenian S, Benya EC, Bobbey AJ, Chang V, Cooper S, Coulter DW, Cuglievan B, Hoppe BS, Isenalumhe L, Kelly K, Kersun L, Lamble AJ, Larrier NA, Magee J, Oduro K, Pacheco M, Price AP, Roberts KB, Smith CM, Sohani AR, Trovillion EM, Walling E, Xavier AC, Burns JL, Campbell M. Pediatric Hodgkin Lymphoma, Version 3.2021. J Natl Compr Canc Netw. 2021 Jun 30; 19 (6):733-754 Epub 2021 June 30
    View PubMed
  61. Ballas LK, Metzger ML, Milgrom SA, Advani R, Bakst RL, Dabaja BS, Flowers CR, Ha CS, Hoppe BS, Mansur DB, Pinnix CC, Plastaras JP, Roberts KB, Smith SM, Terezakis SA, Constine LS. Nodular lymphocyte predominant Hodgkin lymphoma: executive summary of the American radium society appropriate use criteria. Leuk Lymphoma. 2021 May; 62 (5):1057-1065 Epub 2020 Dec 04
    View PubMed
  62. Bryant CM, Hoppe BS. Promising long-term results with proton therapy for localized prostate cancer. Nat Rev Urol 2021 Mar; 18 (3):137-138
    View PubMed
  63. Kharod SM, Mercado CE, Morris CG, Bryant CM, Mendenhall NP, Mendenhall WM, Nichols RC, Hoppe BS, Liang X, Su Z, Li Z, Henderson RH. Postoperative or Salvage Proton Radiotherapy for Prostate Cancer After Radical Prostatectomy. Int J Part Ther. 2021 Spring; 7 (4):52-64 Epub 2021 Mar 12
    View PubMed
  64. Bojanini L, Jiang L, Tun AJ, Ayala E, Menke DM, Hoppe B, Kharfan-Dabaja MA, Tun HW, Alhaj Moustafa M. Outcomes of Hepatosplenic T-Cell Lymphoma: The Mayo Clinic Experience. Clin Lymphoma Myeloma Leuk. 2021 Feb; 21 (2):106-112.e1 Epub 2020 Oct 05
    View PubMed
  65. Chuong MD, Hallemeier CL, Li H, Zhu XR, Zhang X, Tryggestad EJ, Yu J, Yang M, Choi JI, Kang M, Liu W, Knopf A, Meijers A, Molitoris JK, Apisarnthanarax S, Giap H, Hoppe BS, Lee P, Chang JY, Simone CB 2nd, Lin SH. Executive Summary of Clinical and Technical Guidelines for Esophageal Cancer Proton Beam Therapy From the Particle Therapy Co-Operative Group Thoracic and Gastrointestinal Subcommittees. Front Oncol. 2021; 11:748331 Epub 2021 Oct 19
    View PubMed
  66. Abousaida B, Seneviratne D, Hoppe BS, Ko SJ, Asaithamby A, Cucinotta FA, Kirwan JM, Mody K, Toskich B, Ashman JB, Hallemeier CL, Krishnan S. Carbon Ion Radiotherapy in the Management of Hepatocellular Carcinoma. J Hepatocell Carcinoma. 2021; 8:1169-1179 Epub 2021 Sept 24
    View PubMed
  67. Tseng YD, Hoppe BS, Dedeckova K, Patel CG, Hill-Kayser CE, Miller DM, Maity A, Mendenhall NP, Mailhot Vega RB, Yock TI, Baliga S, Hess CB, Winkfield KM, Mohindra P, Rosen LR, Tsai H, Chang J, Hartsell WF, Plastaras JP. Risk of Pneumonitis and Outcomes After Mediastinal Proton Therapy for Relapsed/Refractory Lymphoma: A PTCOG and PCG Collaboration. Int J Radiat Oncol Biol Phys. 2021 Jan 1; 109 (1):220-230 Epub 2020 Aug 28
    View PubMed
  68. Shrestha S, Gupta AC, Bates JE, Lee C, Owens CA, Hoppe BS, Constine LS, Smith SA, Qiao Y, Weathers RE, Yasui Y, Court LE, Paulino AC, Pinnix CC, Kry SF, Followill DS, Armstrong GT, Howell RM. Development and validation of an age-scalable cardiac model with substructures for dosimetry in late-effects studies of childhood cancer survivors. Radiother Oncol. 2020 Dec; 153:163-171 Epub 2020 Oct 17
    View PubMed
  69. De Leo AN, Bates JE, Lockney NA, Mendenhall NP, Shaikh ME, Morris CG, Hoppe BS. Radiotherapy in Early-stage Gastric MALT: Improved Survival Without Increased Cardiac Death. Am J Clin Oncol. 2020 Nov; 43 (11):770-775
    View PubMed
  70. Kharod SM, Nichols RC, Henderson RH, Morris CG, Pham DC, Seeram VK, Jones LM, Antonio-Miranda M, Huh S, Li Z, Hoppe BS. Image-guided hypofractionated double-scattering proton therapy in the management of centrally-located early-stage non-small cell lung cancer. Acta Oncol. 2020 Oct; 59 (10):1164-1170 Epub 2020 May 12
    View PubMed
  71. Kharod SM, Nichols RC, Henderson RH, Morris CG, Pham DC, Seeram VK, Jones LM, Antonio-Miranda M, Siragusa DA, Li Z, Flampouri S, Hoppe BS. Image-Guided Hypofractionated Proton Therapy in Early-Stage Non-Small Cell Lung Cancer: A Phase 2 Study. Int J Part Ther. 2020 Fall; 7 (2):1-10 Epub 2020 Nov 06
    View PubMed
  72. Malouff TD, Vallow LA, Seneviratne D, Mahajan A, Foote RL, Hoppe B, Beltran C, Buskirk SJ, Krishnan S, Trifiletti DM. Estimating the Number of Patients Eligible for Carbon Ion Radiotherapy in the United States. Int J Part Ther. 2020 Fall; 7(2):31-41. Epub 2020 Nov 05.
    View PubMed
  73. Wirth A, Mikhaeel NG, Aleman BMP, Pinnix CC, Constine LS, Ricardi U, Illidge TM, Eich HT, Hoppe BS, Dabaja B, Ng AK, Kirova Y, Berthelsen AK, Dieckmann K, Yahalom J, Specht L. Involved Site Radiation Therapy in Adult Lymphomas: An Overview of International Lymphoma Radiation Oncology Group Guidelines. Int J Radiat Oncol Biol Phys. 2020 Aug 1; 107 (5):909-933 Epub 2020 Apr 07
    View PubMed
  74. Bates JE, Parikh RR, Mendenhall NP, Morris CG, Hoppe RT, Constine LS, Hoppe BS. Long-Term Outcomes in 10-Year Survivors of Early-Stage Hodgkin Lymphoma. Int J Radiat Oncol Biol Phys. 2020 Jul 1; 107 (3):522-529 Epub 2020 Mar 12
    View PubMed
  75. Hoppe BS, Nichols RC, Flampouri S, Li Z, Morris CG, Pham DC, Mohindra P, Hartsell W, Mohammed N, Chon BH, Simone CB 2nd. Hypofractionated Proton Therapy with Concurrent Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Phase 1 Trial from the University of Florida and Proton Collaborative Group. Int J Radiat Oncol Biol Phys. 2020 Jul 1; 107 (3):455-461 Epub 2020 Apr 03
    View PubMed
  76. Malouff TD, Krishnan S, Hallemeier CL, Haddock MG, Hoppe BS, Beltran C, Mahajan A, Trifiletti DM. Carbon Ion Radiotherapy in the Treatment of Pancreatic Cancer: A Review. Pancreas. 2020 Jul; 49 (6):737-743
    View PubMed
  77. Binkley MS, Rauf MS, Milgrom SA, Pinnix CC, Tsang R, Dickinson M, Ng AK, Roberts KB, Gao S, Balogh A, Ricardi U, Levis M, Casulo C, Stolten M, Specht L, Plastaras JP, Wright C, Kelsey CR, Brady JL, Mikhaeel NG, Hoppe BS, Terezakis SA, Picardi M, Della Pepa R, Kirova Y, Akhtar S, Maghfoor I, Koenig JL, Jackson C, Song E, Sehgal S, Advani RH, Natkunam Y, Constine LS, Eich HT, Wirth A, Hoppe RT. Stage I-II nodular lymphocyte-predominant Hodgkin lymphoma: a multi-institutional study of adult patients by ILROG. Blood. 2020 Jun 25; 135 (26):2365-2374
    View PubMed
  78. Malouff TD, Mahajan A, Mutter RW, Krishnan S, Hoppe BS, Beltran C, Trifiletti DM, Vallow LA. Carbon ion radiation therapy in breast cancer: a new frontier. Breast Cancer Res Treat. 2020 Jun; 181 (2):291-296 Epub 2020 Apr 21
    View PubMed
  79. Saifi O, Kharfan-Dabaja MA, Zeidan YH, Peterson J, Rule WG, Lester SC, Hoppe BS. Proton Therapy as a Bridging Treatment in CAR T-Cell Therapy for Relapsed and Refractory Large B-Cell Lymphoma: Is There a Role? Int J Part Ther. 2020 Summer; 7 (1):13-20 Epub 2020 June 03
    View PubMed
  80. Hoppe BS, Bates JE, Mendenhall NP, Morris CG, Louis D, Ho MW, Hoppe RT, Shaikh M, Li Z, Flampouri S. The Meaningless Meaning of Mean Heart Dose in Mediastinal Lymphoma in the Modern Radiation Therapy Era. Pract Radiat Oncol. 2020 May - Jun; 10 (3):e147-e154 Epub 2019 Oct 02
    View PubMed
  81. Mailhot Vega RB, Hoppe BS. A positive approach: advances in proton therapy for the treatment of mediastinal lymphoma. Expert Rev Hematol 2020 Mar; 13 (3):197-200 Epub 2020 Feb 24
    View PubMed
  82. Khullar K, Rivera-Nunez Z, Jhawar SR, Drachtman R, Cole PD, Hoppe BS, Parikh RR. Pediatric hodgkin lymphoma: disparities in survival by race. Leuk Lymphoma. 2020 Mar; 61 (3):546-556 Epub 2019 Oct 23
    View PubMed
  83. Hoppe BS, Mailhot Vega RB, Mendenhall NP, Sandler ES, Slayton WB, Katzenstein H, Joyce MJ, Li Z, Flampouri S. Irradiating Residual Disease to 30 Gy with Proton Therapy in Pediatric Mediastinal Hodgkin Lymphoma. Int J Part Ther. 2020 Spring; 6 (4):11-16 Epub 2020 Apr 27
    View PubMed
  84. Verma V, Wegner RE, Stahl JM, Barsky AR, Raghavan D, Busquets TE, Hoppe BS, Grover S, Friedberg JS, Simone CB 2nd. Impact of Detecting Occult Pathologic Nodal Disease During Resection for Malignant Pleural Mesothelioma. Clin Lung Cancer. 2020 Jan 23 [Epub ahead of print]
    View PubMed
  85. Mishra MV, Thayer WM, Janssen E, Hoppe B, Eggleston C, Bridges JFP. Patient preferences for reducing bowel adverse events following prostate radiotherapy. PLoS One. 2020; 15 (7):e0235616 Epub 2020 July 08
    View PubMed
  86. Everett AS, Hoppe BS, Louis D, McDonald AM, Morris CG, Mendenhall NP, Li Z, Flampouri S. Comparison of Techniques for Involved-Site Radiation Therapy in Patients With Lower Mediastinal Lymphoma. Pract Radiat Oncol. 2019 Nov; 9 (6):426-434 Epub 2019 May 22
    View PubMed
  87. Wieland J, Hoppe BS, Rausch-Osian SM, King JC, Sierra A, Hiemenz JW, Bradley J, Pham DC, Jones LM, Yeung AR, Hopper K, Mendenhall NP, Hitchcock KE. Survivor and Caregiver Expectations and Preferences Regarding Lung Cancer Treatment. Int J Part Ther. 2019 Fall; 6 (2):42-49 Epub 2019 Nov 26
    View PubMed
  88. Bates JE, Morris CG, Milano MT, Yeung AR, Hoppe BS. Immunotherapy with hypofractionated radiotherapy in metastatic non-small cell lung cancer: An analysis of the National Cancer Database. Radiother Oncol. 2019 Sep; 138:75-79 Epub 2019 June 25
    View PubMed
  89. Badiyan SN, Rutenberg MS, Hoppe BS, Mohindra P, Larson G, Hartsell WF, Tsai H, Zeng J, Rengan R, Glass E, Katz S, Vargas C, Feigenberg SJ, Simone CB 2nd. Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated With Proton Therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies. Pract Radiat Oncol. 2019 Jul - Aug; 9 (4):280-288 Epub 2019 Feb 23
    View PubMed
  90. Mercado CE, Hartsell WF, Simone CB 2nd, Tsai HK, Vargas CE, Zhu HJ, Henderson RH, Zeng J, Larson GL, Hoppe BS. Proton therapy for thymic malignancies: multi-institutional patterns-of-care and early clinical outcomes from the proton collaborative group and the university of Florida prospective registries. Acta Oncol. 2019 Jul; 58 (7):1036-1040 Epub 2019 Feb 20
    View PubMed
  91. Lockney NA, Zhang M, Morris CG, Nichols RC, Okunieff P, Swarts S, Zhang Z, Zhang B, Zhang A, Hoppe BS. Radiation-induced tumor immunity in patients with non-small cell lung cancer. Thorac Cancer. 2019 Jul; 10 (7):1605-1611 Epub 2019 June 22
    View PubMed
  92. Guzhva L, Flampouri S, Mendenhall NP, Morris CG, Hoppe BS. Intrafractional Displacement of Cardiac Substructures Among Patients With Mediastinal Lymphoma or Lung Cancer. Adv Radiat Oncol. 2019 Jul-Sep; 4 (3):500-506 Epub 2019 Mar 29
    View PubMed
  93. Holtzman AL, Bryant CM, Mendenhall NP, Mendenhall WM, Nichols RC, Henderson RH, Figura N, Morris CG, Williams CR, Li Z, Hoppe BS. Patient-Reported Sexual Survivorship Following High-Dose Image-Guided Proton Therapy for Prostate Cancer. Radiother Oncol. 2019 May; 134:204-210. Epub 2019 Feb 27.
    View PubMed
  94. Jhawar SR, Rivera-Nunez Z, Drachtman R, Cole PD, Hoppe BS, Parikh RR. Association of Combined Modality Therapy vs Chemotherapy Alone With Overall Survival in Early-Stage Pediatric Hodgkin Lymphoma. JAMA Oncol. 2019 May 1; 5 (5):689-695
    View PubMed
  95. Zhu HJ, Nichols RC, Henderson RH, Morris CG, Flampouri S, Pham DC, Klassen CL, Seeram V, Cury JD, Jones L, McGee L, Hoppe BS. Impact of unfavorable factors on outcomes among inoperable stage II-IV Nonsmall cell lung cancer patients treated with proton therapy. Acta Oncol. 2019 Mar; 58 (3):313-319 Epub 2019 Jan 18
    View PubMed
  96. Bates JE, Klassen C, Ozdemir S, Flampouri S, Percy R, Mendenhall NP, Hoppe BS. Cardiac MRI for Detecting Early Cardiac Toxicity following Proton Therapy for Hodgkin Lymphoma. International Journal of Particle Therapy. 2019; 5(4):41-44.
    View PubMed
  97. Su Z, Li Z, Henderson R, Hoppe B, Nichols RC, Bryant C, Mendenhall W, Mendenhall N. PTV margin analysis for prostate patients treated with initial pelvic nodal IMRT and prostate proton boost. Phys Med Biol. 2019 Feb 8; 64 (4):04NT04 Epub 2019 Feb 08
    View PubMed
  98. O’Steen L, Bellardini J, Cury J, Jones L, Seeram V, Mendenhall NP, Hoppe BS. Pulmonary Function after Proton Therapy for Hodgkin Lymphoma International Journal of Particle Therapy. 2019; 5(3):1-4.
    View PubMed
  99. Holtzman AL, Stahl JM, Zhu S, Morris CG, Hoppe BS, Kirwan JE, Mendenhall NP. Does the Incidence of Treatment-Related Toxicity Plateau After Radiation Therapy: The Long-Term Impact of Integral Dose in Hodgkin's Lymphoma Survivors. Adv Radiat Oncol. 2019 Oct-Dec; 4(4):699-705. Epub 2019 Jul 23.
    View PubMed
  100. Nichols RC, Morris CG, Bryant C, Hoppe BS, Henderson RH, Mendenhall WM, Li Z, Costa JA, Williams CR, Mendenhall NP. Serum Testosterone 60 Months after Passive-Scatter Proton Therapy for Localized Prostate Cancer. Cancer Invest. 2019; 37 (2):85-89 Epub 2019 Mar 05
    View PubMed
  101. Liang X, Zheng D, Mamalui-Hunter M, Flampouri S, Hoppe BS, Mendenhall N, Li Z. ITV-Based Robust Optimization for VMAT Planning of Stereotactic Body Radiation Therapy of Lung Cancer. Pract Radiat Oncol. 2019 Jan; 9 (1):38-48 Epub 2018 Aug 20
    View PubMed
  102. Mendenhall WM, Sarto G, Bryant CM, Morris CG, Williams CR, Costa JA, Bandyk M, Hoppe BS, Henderson RH, Nichols RC, Mendenhall NP. Rectal Culture and Sensitivity Analysis for Reducing Sepsis Risk After Fiducial Marker Placement. Am J Clin Oncol. 2018 Dec; 41 (12):1243-1245
    View PubMed
  103. Dabaja BS, Hoppe BS, Plastaras JP, Newhauser W, Rosolova K, Flampouri S, Mohan R, Mikhaeel NG, Kirova Y, Specht L, Yahalom J. Proton therapy for adults with mediastinal lymphomas: the International Lymphoma Radiation Oncology Group guidelines. Blood. 2018 Oct 18; 132 (16):1635-1646 Epub 2018 Aug 14
    View PubMed
  104. Okunieff P, Casey-Sawicki K, Lockney NA, Hoppe BS, Enderling H, Pinnix C, Welsh J, Krishnan S, Yothers G, Brown M, Knox S, Bristow R, Spellman P, Mitin T, Nabavizadeh N, Jaboin J, Manning HC, Feng F, Galbraith S, Solanki AA, Harkenrider MM, Tuli R, Decker RH, Finkelstein SE, Hsu CC, Ha CS, Jagsi R, Shumway D, Daly M, Wang TJC, Fitzgerald TJ, Laurie F, Marshall DT, Raben D, Constine L, Thomas CR Jr, Kachnic LA. Report from the SWOG Radiation Oncology Committee: Research Objectives Workshop 2017. Clin Cancer Res. 2018 Aug 1; 24 (15):3500-3509 Epub 2018 Apr 16
    View PubMed
  105. Kenney LB, Antal Z, Ginsberg JP, Hoppe BS, Bober SL, Yu RN, Constine LS, van Santen HM, Skinner R, Green DM. Improving Male Reproductive Health After Childhood, Adolescent, and Young Adult Cancer: Progress and Future Directions for Survivorship Research. J Clin Oncol. 2018 Jul 20; 36 (21):2160-2168 Epub 2018 June 06
    View PubMed
  106. Weber DC, Habrand JL, Hoppe BS, Hill Kayser C, Laack NN, Langendijk JA, MacDonald SM, McGovern SL, Pater L, Perentesis JP, Thariat J, Timmerman B, Yock TI, Mahajan A. Proton therapy for pediatric malignancies: Fact, figures and costs. A joint consensus statement from the pediatric subcommittee of PTCOG, PROS and EPTN. Radiother Oncol. 2018 Jul; 128 (1):44-55 Epub 2018 June 21
    View PubMed
  107. Ho CK, Bryant CM, Mendenhall NP, Henderson RH, Mendenhall WM, Nichols RC, Morris CG, Kanmaniraja D, Hamlin DJ, Li Z, Hoppe BS. Long-term outcomes following proton therapy for prostate cancer in young men with a focus on sexual health. Acta Oncol. 2018 May; 57 (5):582-588 Epub 2018 Jan 23
    View PubMed
  108. Zhu HJ, Hoppe BS, Flampouri S, Louis D, Pirris J, Nichols RC, Henderson RH, Mercado CE. Rationale and early outcomes for the management of thymoma with proton therapy. Transl Lung Cancer Res. 2018 Apr; 7 (2):106-113
    View PubMed
  109. Ng AK, Yahalom J, Goda JS, Constine LS, Pinnix CC, Kelsey CR, Hoppe B, Oguchi M, Suh CO, Wirth A, Qi S, Davies A, Moskowitz CH, Laskar S, Li Y, Mauch PM, Specht L, Illidge T. Role of Radiation Therapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys. 2018 Mar 1; 100 (3):652-669
    View PubMed
  110. Zhu S, Lightsey JL, Hoppe BS, Okunieff P, Gopalan PK, Kaye FJ, Morris CG, Yeung AR. Stereotactic Ablative Body Radiotherapy for Primary Non-Small-Cell Lung Cancer: Achieving Local Control with a Lower Biologically Effective Dose. Cancer Invest. 2018; 36 (5):289-295 Epub 2018 July 24
    View PubMed
  111. Tseng YD, Cutter DJ, Plastaras JP, Parikh RR, Cahlon O, Chuong MD, Dedeckova K, Khan MK, Lin SY, McGee LA, Shen EY, Terezakis SA, Badiyan SN, Kirova YM, Hoppe RT, Mendenhall NP, Pankuch M, Flampouri S, Ricardi U, Hoppe BS. Evidence-based Review on the Use of Proton Therapy in Lymphoma From the Particle Therapy Cooperative Group (PTCOG) Lymphoma Subcommittee. Int J Radiat Oncol Biol Phys. 2017 Nov 15; 99 (4):825-842 Epub 2017 Sept 21
    View PubMed
  112. Nanda R, Flampouri S, Mendenhall NP, Indelicato DJ, Jones LM, Seeram VK, Hoppe BS. Pulmonary Toxicity Following Proton Therapy for Thoracic Lymphoma. Int J Radiat Oncol Biol Phys. 2017 Oct 1; 99 (2):494-497 Epub 2017 Apr 11
    View PubMed
  113. Pham DC, Awad Z, Hoppe BS, Hew J, Ning K. Metastasectomy of Solitary Adrenal Metastasis From Small Cell Lung Cancer. J Investig Med High Impact Case Rep. 2017 Oct-Dec; 5 (4):2324709617740909 Epub 2017 Nov 03
    View PubMed
  114. Henderson RH, Bryant C, Hoppe BS, Nichols RC, Mendenhall WM, Flampouri S, Su Z, Li Z, Morris CG, Mendenhall NP. Five-year outcomes from a prospective trial of image-guided accelerated hypofractionated proton therapy for prostate cancer. Acta Oncol. 2017 Jul; 56 (7):963-970 Epub 2017 Feb 22
    View PubMed
  115. Flerlage JE, Kelly KM, Beishuizen A, Cho S, De Alarcon PA, Dieckmann U, Drachtman RA, Hoppe BS, Howard SC, Kaste SC, Kluge R, Kurch L, Landman-Parker J, Lewis J, Link MP, McCarten K, Punnett A, Stoevesandt D, Voss SD, Wallace WH, Mauz-Korholz C, Metzger ML. Staging Evaluation and Response Criteria Harmonization (SEARCH) for Childhood, Adolescent and Young Adult Hodgkin Lymphoma (CAYAHL): Methodology statement. Pediatr Blood Cancer. 2017 Jul; 64 (7) Epub 2017 Jan 18
    View PubMed
  116. Filippi AR, Levis M, Parikh R, Hoppe B. Optimal Therapy for Early-Stage Hodgkin's Lymphoma: Risk Adapting, Response Adapting, and Role of Radiotherapy. Curr Oncol Rep. 2017 May; 19 (5):34
    View PubMed
  117. Figura N, Flampouri S, Mendenhall NP, Morris CG, McCook B, Ozdemir S, Slayton W, Sandler E, Hoppe BS. Importance of baseline PET/CT imaging on radiation field design and relapse rates in patients with Hodgkin lymphoma. Adv Radiat Oncol. 2017 Apr-Jun; 2 (2):197-203 Epub 2017 Jan 18
    View PubMed
  118. Guzhva L, Mendenhall NP, Morris CG, Flampouri S, Hoppe BS. Evaluating Cardiac Biomarkers after Chemotherapy and Proton Therapy for Mediastinal Hodgkin Lymphoma. International Journal of Particle Therapy. 2017; 4(2):35-38.
    View PubMed
  119. Bryant C, Hoppe BS, Henderson RH, Nichols RC, Mendenhall WM, Smith TL, Morris CG, Williams CR, Su Z, Li Z, Mendenhall NP. Race does not affect tumor control, adverse effects, or QOL after Proton therapy International Journal of Particle Therapy. 2017; 3(4):450-460.
    View PubMed
  120. Hoppe BS, Mendenhall NP, Louis D, Li Z, Flampouri S. Comparing Breath Hold and Free Breathing techniques for IMRT and Proton Therapy in Patients with Mediastinal Hodgkin lymphoma International Journal of Particle Therapy. 2017; 3(4):492-496.
    View PubMed
  121. Winkfield KM, Advani RH, Ballas LK, Dabaja BS, Dhakal S, Flowers CR, Ha CS, Hoppe BS, Mansur DB, Mendenhall NP, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Smith SM, Terezakis SA, Younes A, Constine LS. ACR Appropriateness Criteria(R) Recurrent Hodgkin Lymphoma. Oncology (Williston Park). 2016 Dec 15; 30 (12):1099-103, 1106-8
    View PubMed
  122. Dhakal S, Advani R, Ballas LK, Dabaja BS, Flowers CR, Ha CS, Hoppe BS, Mendenhall NP, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Smith SM, Terezakis SA, Winkfield KM, Younes A, Constine LS, Expert Panel on Radiation Oncology-Lymphoma. ACR Appropriateness Criteria(R) Hodgkin Lymphoma-Favorable Prognosis Stage I and II. Am J Clin Oncol. 2016 Dec; 39 (6):535-544
    View PubMed
  123. Hoppe BS, Tsai H, Larson G, Laramore GE, Vargas C, Tseng YD, Dunn M, McGee L, Cahlon O, Hartsell W. Proton therapy patterns-of-care and early outcomes for Hodgkin lymphoma: results from the Proton Collaborative Group Registry. Acta Oncol. 2016 Nov; 55 (11):1378-1380 Epub 2016 Aug 31
    View PubMed
  124. Wray J, Flampouri S, Slayton W, Joyce M, Sandler E, Morris CG, Li Z, Indelicato DJ, Mendenhall NP, Hoppe BS. Proton Therapy for Pediatric Hodgkin Lymphoma. Pediatr Blood Cancer. 2016 Sep; 63 (9):1522-6 Epub 2016 May 03
    View PubMed
  125. Roberts KB, Younes A, Hodgson DC, Advani R, Dabaja BS, Dhakal S, Flowers CR, Ha CS, Hoppe BS, Mendenhall NP, Metzger ML, Plastaras JP, Shapiro R, Smith SM, Terezakis SA, Winkfield KM, Constine LS, Expert Panel on Radiation OncologyLymphoma. ACR Appropriateness Criteria(R) Hodgkin Lymphoma-Unfavorable Clinical Stage I and II. Am J Clin Oncol. 2016 Aug; 39 (4):384-95
    View PubMed
  126. Bryant C, Henderson RH, Hoppe BS, Mendenhall WM, Nichols RC, Su Z, Li Z, Mendenhall NP. Controversies in proton therapy for prostate cancer. Chin Clin Oncol. 2016 Aug; 5 (4):55
    View PubMed
  127. Bryant C, Mendenhall NP, Henderson RH, Nichols RC, Mendenhall WM, Morris CG, Williams C, Su Z, Li Z, Hoppe BS. Does Race Influence Health-related Quality of Life and Toxicity Following Proton Therapy for Prostate Cancer? Am J Clin Oncol. 2016 Jun; 39 (3):261-5
    View PubMed
  128. Chang JY, Jabbour SK, De Ruysscher D, Schild SE, Simone CB 2nd, Rengan R, Feigenberg S, Khan AJ, Choi NC, Bradley JD, Zhu XR, Lomax AJ, Hoppe BS, International Particle Therapy Co-operative Group (PTCOG) Thoracic Subcommittee. Consensus Statement on Proton Therapy in Early-Stage and Locally Advanced Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2016 May 1; 95 (1):505-516 Epub 2016 Jan 23
    View PubMed
  129. Bryant C, Smith TL, Henderson RH, Hoppe BS, Mendenhall WM, Nichols RC, Morris CG, Williams CR, Su Z, Li Z, Lee D, Mendenhall NP. Five-Year Biochemical Results, Toxicity, and Patient-Reported Quality of Life After Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate Cancer. Int J Radiat Oncol Biol Phys. 2016 May 1; 95 (1):422-34 Epub 2016 Feb 16
    View PubMed
  130. Hoppe BS, Henderson R, Pham D, Cury JD, Bajwa A, Morris CG, D'Agostino H Jr, Flampouri S, Huh S, Li Z, McCook B, Nichols RC Jr. A Phase 2 Trial of Concurrent Chemotherapy and Proton Therapy for Stage III Non-Small Cell Lung Cancer: Results and Reflections Following Early Closure of a Single-Institution Study. Int J Radiat Oncol Biol Phys. 2016 May 1; 95 (1):517-22 Epub 2015 Nov 10
    View PubMed
  131. Holtzman AL, Hoppe BS, Letter HP, Bryant C, Nichols RC, Henderson RH, Mendenhall WM, Morris CG, Williams CR, Li Z, Mendenhall NP. Proton Therapy as Salvage Treatment for Local Relapse of Prostate Cancer Following Cryosurgery or High-Intensity Focused Ultrasound. Int J Radiat Oncol Biol Phys. 2016 May 01; 95(1):465-471. Epub 2015 Dec 19.
    View PubMed
  132. Mendenhall WM, Glassman G, Morris CG, Costa JA, Williams CR, Harris SE, Mandia SE, Hoppe BS, Henderson RH, Bryant CM, Nichols RC, Mendenhall NP. Bacterial UTI after Transrectal Placement of Fiducial Markers prior to Proton Therapy for Prostate Cancer International Journal of Particle Therapy. 2016; 3(1):21-26.
    View PubMed
  133. Lee DT, Mendenhall NP, Smith TL, Morris CG, Nichols RC, Bryant C, Henderson RH, Mendenhall WM , Williams CR, Costa J, Li Z, Hoppe BS. Quality of Life after Transurethral Resection of the Prostate and HD-IGRT for Prostate Cancer International Journal of Particle Therapy. 2016; 2(4):518-524.
    View PubMed
  134. Dabaja BS, Advani R, Hodgson DC, Dhakal S, Flowers CR, Ha CS, Hoppe BS, Mendenhall NP, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Smith SM, Terezakis SA, Winkfield KM, Younes A, Constine LS. ACR Appropriateness Criteria(R) Diffuse Large B-Cell Lymphoma. Am J Clin Oncol. 2015 Dec; 38 (6):610-20
    View PubMed
  135. Sachsman S, Hoppe BS, Mendenhall NP, Holtzman A, Li Z, Slayton W, Joyce M, Sandler E, Flampouri S. Proton therapy to the subdiaphragmatic region in the management of patients with Hodgkin lymphoma. Leuk Lymphoma. 2015 Jul; 56(7):2019-24. Epub 2014 Nov 19.
    View PubMed
  136. Mendenhall WM, Henderson RH, Costa JA, Hoppe BS, Dagan R, Bryant CM, Nichols RC, Williams CR, Harris SE, Mendenhall NP. Hemorrhagic radiation cystitis. Am J Clin Oncol. 2015 Jun; 38 (3):331-6
    View PubMed
  137. Hoppe BS, Hoppe RT. Expert radiation oncologist interpretations of involved-site radiation therapy guidelines in the management of Hodgkin lymphoma. Int J Radiat Oncol Biol Phys. 2015 May 1; 92 (1):40-5
    View PubMed
  138. Hoppe BS, Bryant C, Sandler HM. Radiation for prostate cancer: intensity modulated radiation therapy versus proton beam. J Urol. 2015 Apr; 193 (4):1089-91 Epub 2015 Jan 15
    View PubMed
  139. Bryant C, Hoppe BS, Mendenhall NP, Henderson RH, Nichols RC, Morris CG, Williams CR, Harris SE, Su Z, Li Z, Mendenhall WM. Testosterone Replacement Therapy in Men with Prostate Cancer after Proton Therapy International Journal of Particle Therapy. 2015; 1(3):682-691.
  140. Colaco RJ, Hoppe BS, Flampouri S, McKibben BT, Henderson RH, Bryant C, Nichols RC, Mendenhall WM, Li Z, Su Z, Morris CG, Mendenhall NP. Rectal toxicity after proton therapy for prostate cancer: an analysis of outcomes of prospective studies conducted at the university of Florida Proton Therapy Institute. Int J Radiat Oncol Biol Phys. 2015 Jan 1; 91 (1):172-81 Epub 2014 Nov 05
    View PubMed
  141. Sachsman S, Flampouri S, Li Z, Lynch J, Mendenhall NP, Hoppe BS. Proton therapy in the management of non-Hodgkin lymphoma. Leuk Lymphoma. 2015; 56 (9):2608-12 Epub 2015 May 18
    View PubMed
  142. Ha CS, Hodgson DC, Advani R, Dabaja BS, Dhakal S, Flowers CR, Hoppe BS, Mendenhall NP, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Smith S, Terezakis SA, Winkfield KM, Younes A, Constine LS. ACR appropriateness criteria follow-up of Hodgkin lymphoma. J Am Coll Radiol. 2014 Nov; 11 (11):1026-1033.e3 Epub 2014 Sept 30
    View PubMed
  143. Ho CK, Flampouri S, Hoppe BS. Proton therapy in the management of lymphoma. Cancer J. 2014 Nov-Dec; 20 (6):387-92
    View PubMed
  144. Mendenhall WM, McKibben BT, Hoppe BS, Nichols RC, Henderson RH, Mendenhall NP. Management of radiation proctitis. Am J Clin Oncol. 2014 Oct; 37 (5):517-23
    View PubMed
  145. Hoppe BS, Flampouri S, Zaiden R, Slayton W, Sandler E, Ozdemir S, Dang NH, Lynch JW, Li Z, Morris CG, Mendenhall NP. Involved-node proton therapy in combined modality therapy for Hodgkin lymphoma: results of a phase 2 study. Int J Radiat Oncol Biol Phys. 2014 Aug 1; 89 (5):1053-1059 Epub 2014 June 10
    View PubMed
  146. Mendenhall WM, Henderson RH, Hoppe BS, Nichols RC, Mendenhall NP. Salvage of locally recurrent prostate cancer after definitive radiotherapy. Am J Clin Oncol. 2014 Aug; 37 (4):411-6
    View PubMed
  147. Terezakis SA, Metzger ML, Hodgson DC, Schwartz CL, Advani R, Flowers CR, Hoppe BS, Ng A, Roberts KB, Shapiro R, Wilder RB, Yunes MJ, Constine LS. ACR Appropriateness Criteria Pediatric Hodgkin Lymphoma. Pediatr Blood Cancer. 2014 Jul; 61 (7):1305-12 Epub 2014 Feb 24
    View PubMed
  148. Hoppe BS, Michalski JM, Mendenhall NP, Morris CG, Henderson RH, Nichols RC, Mendenhall WM, Williams CR, Regan MM, Chipman JJ, Crociani CM, Sandler HM, Sanda MG, Hamstra DA. Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancer. Cancer. 2014 Apr 1; 120 (7):1076-82 Epub 2013 Dec 30
    View PubMed
  149. Mendenhall NP, Hoppe BS, Nichols RC, Mendenhall WM, Morris CG, Li Z, Su Z, Williams CR, Costa J, Henderson RH. Five-year outcomes from 3 prospective trials of image-guided proton therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2014 Mar 1; 88 (3):596-602
    View PubMed
  150. Colaco RJ, Nichols RC, Huh S, Getman N, Ho MW, Li Z, Morris CG, Mendenhall WM, Mendenhall NP, Hoppe BS. Protons offer reduced bone marrow, small bowel, and urinary bladder exposure for patients receiving neoadjuvant radiotherapy for resectable rectal cancer. J Gastrointest Oncol. 2014 Feb; 5 (1):3-8
    View PubMed
  151. Sachsman S, Nichols RC, Morris CG, Zaiden R, Johnson EA, Awad Z, Bose D, Ho MW, Huh SN, Li Z, Kelly P, Hoppe BS. Proton Therapy and Concomitant Capecitabine for Non-Metastatic Unresectable Pancreatic Adenocarcinoma International Journal of Particle Therapy. 2014; 1(3):692-701.
  152. Holtzman A, Hoppe BS, Li Z, Slayton W, Sandler E, Joyce M, Ozdemir S, Mendenhall NP, Flampouri S. Advancing the Therapeutic Index of Pediatric Patients with Stage III Hodgkin Lymphoma with Proton Therapy International Journal of Particle Therapy. 2014; 1(2):343-356.
  153. Kil WJ, Mendenhall NP, Morris CG, Nichols RC, Henderson RH, Mendenhall WM, Bryant C, Williams C, Li Z, Hoppe BS. Patient reported Hip Symptoms following Treatment with Proton Therapy for Prostate Cancer International Journal of Particle Therapy. 2014; 1(1):14-21.
  154. Mendenhall WM, Costa JA, Williams CR, Harris SE, Mandia SE, Hoppe BS, Henderson RH, Bryant CM, Nichols RC, Mendenhall NP. Bacterial Urinary Tract Infection after Fiducial Marker Placement or Prostate Biopsy International Journal of Particle Therapy. 2014; 4(3):745-758.
  155. Mendenhall WM, Hoppe BS, Nichols RC, Henderson RH, Mendenhall NP. When is elective pelvic lymph node irradiation indicated in definitive radiotherapy for localized prostate cancer? Am J Clin Oncol. 2013 Dec; 36 (6):644-7
    View PubMed
  156. Mendenhall WM, Henderson RH, Hoppe BS, Nichols RC, Mendenhall NP. Androgen deprivation therapy and definitive radiotherapy for prostate cancer. Am J Clin Oncol. 2013 Oct; 36 (5):530-4
    View PubMed
  157. Hoppe BS, Hodgson DC, Advani R, Dabaja BS, Flowers CR, Ha CS, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Terezakis SA, Winkfield KM, Younes A, Constine LS. ACR Appropriateness Criteria: Localized nodal indolent lymphoma. Oncology (Williston Park). 2013 Aug; 27 (8):786-94
    View PubMed
  158. Figura N, Hoppe BS, Flampouri S, Su Z, Osian O, Monroe A, Nichols RC. Postoperative proton therapy in the management of stage III thymoma. J Thorac Oncol. 2013 May; 8 (5):e38-40
    View PubMed
  159. Shi W, Nichols RC Jr, Flampouri S, Li Z, Hsi W, Huh S, Ho MW, Henderson RH, Mendenhall NP, Hoppe BS. Proton-based chemoradiation for synchronous bilateral non-small-cell lung cancers: A case report. Thorac Cancer. 2013 May; 4 (2):198-202
    View PubMed
  160. McGee L, Mendenhall NP, Henderson RH, Morris CG, Nichols RC Jr, Marcus RJ Jr, Li Z, Mendenhall WM, Williams CR, Hoppe BS. Outcomes in men with large prostates (>/= 60 cm(3)) treated with definitive proton therapy for prostate cancer. Acta Oncol. 2013 Apr; 52 (3):470-6 Epub 2012 Dec 17
    View PubMed
  161. Valery R, Mendenhall NP, Nichols RC Jr, Henderson R, Morris CG, Su Z, Mendenhall WM, Williams CR, Li Z, Hoppe BS. Hip fractures and pain following proton therapy for management of prostate cancer. Acta Oncol. 2013 Apr; 52 (3):486-91 Epub 2013 Jan 29
    View PubMed
  162. Nichols RC Jr, George TJ, Zaiden RA Jr, Awad ZT, Asbun HJ, Huh S, Ho MW, Mendenhall NP, Morris CG, Hoppe BS. Proton therapy with concomitant capecitabine for pancreatic and ampullary cancers is associated with a low incidence of gastrointestinal toxicity. Acta Oncol. 2013 Apr; 52 (3):498-505
    View PubMed
  163. Colaco RJ, Huh S, Nichols RC, Morris CG, D'Agostino H, Flampouri S, Li Z, Pham DC, Bajwa AA, Hoppe BS. Dosimetric rationale and early experience at UFPTI of thoracic proton therapy and chemotherapy in limited-stage small cell lung cancer. Acta Oncol. 2013 Apr; 52(3):506-13. Epub 2013 Feb 26.
    View PubMed
  164. Henderson RH, Hoppe BS, Marcus RB Jr, Mendenhall WM, Nichols RC, Li Z, Su Z, Morris CG, Williams CR, Costa J, Mendenhall NP. Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate cancer: results of two prospective trials. Acta Oncol. 2013 Apr; 52 (3):463-9
    View PubMed
  165. Kil WJ, Nichols RC Jr, Hoppe BS, Morris CG, Marcus RB Jr, Mendenhall W, Mendenhall NP, Li Z, Costa JA, Williams CR, Henderson RH. Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression. Acta Oncol. 2013 Apr; 52 (3):492-7
    View PubMed
  166. Hoppe BS, Mamalui-Hunter M, Mendenhall NP, Li Z, Indelicato DJ. Improving the therapeutic ratio by using proton therapy in patients with stage I or II seminoma. Am J Clin Oncol. 2013 Feb; 36 (1):31-7
    View PubMed
  167. Su Z, Zhao T, Li Z, Hoppe B, Henderson R, Mendenhall W, Nichols RC, Marcus R, Mendenhall N. Reduction of prostate intrafraction motion using gas-release rectal balloons. Med Phys. 2012 Oct; 39 (10):5869-73
    View PubMed
  168. Hoppe BS, Flampouri S, Su Z, Latif N, Dang NH, Lynch J, Joyce M, Sandler E, Li Z, Mendenhall NP. Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphoma. Int J Radiat Oncol Biol Phys. 2012 Oct 1; 84 (2):449-55 Epub 2012 Mar 02
    View PubMed
  169. Hoppe BS, Nichols RC, Henderson RH, Morris CG, Williams CR, Costa J, Marcus RB Jr, Mendenhall WM, Li Z, Mendenhall NP. Erectile function, incontinence, and other quality of life outcomes following proton therapy for prostate cancer in men 60 years old and younger. Cancer. 2012 Sep 15; 118 (18):4619-26 Epub 2012 Jan 17
    View PubMed
  170. Hoppe BS, Flampouri S, Henderson RH, Pham D, Bajwa AA, D'Agostino H, Huh SN, Li Z, Mendenhall NP, Nichols RC. Proton therapy with concurrent chemotherapy for non-small-cell lung cancer: technique and early results. Clin Lung Cancer. 2012 Sep; 13(5):352-8. Epub 2012 Jan 20.
    View PubMed
  171. Hoppe BS, Flampouri S, Lynch J, Slayton W, Zaiden R, Li Z, Mendenhall NP. Improving the therapeutic ratio in Hodgkin lymphoma through the use of proton therapy. Oncology (Williston Park). 2012 May; 26 (5):456-9, 462-5
    View PubMed
  172. Nichols RC Jr, Huh SN, Prado KL, Yi BY, Sharma NK, Ho MW, Hoppe BS, Mendenhall NP, Li Z, Regine WF. Protons offer reduced normal-tissue exposure for patients receiving postoperative radiotherapy for resected pancreatic head cancer. Int J Radiat Oncol Biol Phys. 2012 May 1; 83 (1):158-63 Epub 2012 Jan 13
    View PubMed
  173. Nichols RC Jr, Huh SH, Henderson RH, Li Z, Flampouri S, D'Agostino HJ, Cury JD, Pham DC, Mendenhall NP, Hoppe BS. Selective nodal irradiation of regionally advanced non-small-cell lung cancer with proton therapy and IMRT: A dosimetric comparison. Thorac Cancer. 2012 May; 3 (2):169-174
    View PubMed
  174. Hoppe BS, Flampouri S, Su Z, Morris CG, Latif N, Dang NH, Lynch J, Li Z, Mendenhall NP. Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study. Int J Radiat Oncol Biol Phys. 2012 May 1; 83 (1):260-7 Epub 2011 Oct 17
    View PubMed
  175. Nichols RC Jr, Henderson RH, Huh S, Flampouri S, Li Z, Bajwa AA, D'Agostino HJ, Pham DC, Mendenhall NP, Hoppe BS. Proton therapy for lung cancer. Thorac Cancer. 2012 May; 3 (2):109-116
    View PubMed
  176. Smith K, Byer G, Morris CG, Kirwan JM, Lightsey J, Mendenhall NP, Hoppe BS, Lynch J, Olivier K. Outcomes of patients with non-Hodgkin's lymphoma treated with Bexxar with or without external-beam radiotherapy. Int J Radiat Oncol Biol Phys. 2012 Mar 1; 82 (3):1122-7 Epub 2011 May 11
    View PubMed
  177. Nichols RC Jr, Morris CG, Hoppe BS, Henderson RH, Marcus RB Jr, Mendenhall WM, Li Z, Williams CR, Costa JA, Mendenhall NP. Proton radiotherapy for prostate cancer is not associated with post-treatment testosterone suppression. Int J Radiat Oncol Biol Phys. 2012 Mar 1; 82 (3):1222-6 Epub 2011 May 11
    View PubMed
  178. Mendenhall NP, Li Z, Hoppe BS, Marcus RB Jr, Mendenhall WM, Nichols RC, Morris CG, Williams CR, Costa J, Henderson R. Early outcomes from three prospective trials of image-guided proton therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2012 Jan 1; 82 (1):213-21 Epub 2010 Nov 17
    View PubMed
  179. Nichols RC, Huh SN, Henderson RH, Mendenhall NP, Flampouri S, Li Z, D'Agostino HJ, Cury JD, Pham DC, Hoppe BS. Proton radiation therapy offers reduced normal lung and bone marrow exposure for patients receiving dose-escalated radiation therapy for unresectable stage iii non-small-cell lung cancer: a dosimetric study. Clin Lung Cancer. 2011 Jul; 12 (4):252-7 Epub 2011 Apr 27
    View PubMed
  180. Figura NB, Flampouri S, Hopper K, Marcus RB Jr, Mendenhall NP, Hoppe BS. Consolidative Proton Therapy Following High-dose Chemotherapy and Autologous Stem Cell Transplant in an Adolescent with Relapsed Hodgkin Lymphoma. J Adolesc Young Adult Oncol. 2011 Jun; 1 (2):103-6
    View PubMed
  181. Hoppe B, Henderson R, Mendenhall WM, Nichols RC, Li Z, Mendenhall NP. Proton therapy for prostate cancer. Oncology (Williston Park). 2011 Jun; 25 (7):644-50, 652
    View PubMed
  182. Shi W, Nichols RC, Flampouri S, Hsi W, Li Z, Henderson RH, Mendenhall NP, Hoppe BS. Tumor Shrinkage during Proton-based Chemoradiation for Non-small-cell Lung Cancer May Necessitate Adaptive Replanning during Treatment Hong Kong J Radiol. 2011; 14:190-194.
  183. Hoppe BS, Huh S, Flampouri S, Nichols RC, Oliver KR, Morris CG, Mendenhall NP, Li Z. Double-scattered proton-based stereotactic body radiotherapy for stage I lung cancer: a dosimetric comparison with photon-based stereotactic body radiotherapy. Radiother Oncol. 2010 Dec; 97 (3):425-30 Epub 2010 Oct 09
    View PubMed
  184. Gil Z, Carlson DL, Gupta A, Lee N, Hoppe B, Shah JP, Kraus DH. Patterns and incidence of neural invasion in patients with cancers of the paranasal sinuses. Arch Otolaryngol Head Neck Surg. 2009 Feb; 135 (2):173-9
    View PubMed
  185. Hoppe BS, Laser B, Kowalski AV, Fontenla SC, Pena-Greenberg E, Yorke ED, Lovelock DM, Hunt MA, Rosenzweig KE. Acute skin toxicity following stereotactic body radiation therapy for stage I non-small-cell lung cancer: who's at risk? Int J Radiat Oncol Biol Phys. 2008 Dec 1; 72 (5):1283-6
    View PubMed
  186. Hoppe BS, Nelson CJ, Gomez DR, Stegman LD, Wu AJ, Wolden SL, Pfister DG, Zelefsky MJ, Shah JP, Kraus DH, Lee NY. Unresectable carcinoma of the paranasal sinuses: outcomes and toxicities. Int J Radiat Oncol Biol Phys. 2008 Nov 1; 72 (3):763-9 Epub 2008 Apr 18
    View PubMed
  187. Hoppe BS, Wolden SL, Zelefsky MJ, Mechalakos JG, Shah JP, Kraus DH, Lee N. Postoperative intensity-modulated radiation therapy for cancers of the paranasal sinuses, nasal cavity, and lacrimal glands: technique, early outcomes, and toxicity. Head Neck. 2008 Jul; 30 (7):925-32
    View PubMed
  188. Hoppe BS, Moskowitz CH, Filippa DA, Moskowitz CS, Kewalramani T, Zelenetz AD, Yahalom J. Involved-field radiotherapy before high-dose therapy and autologous stem-cell rescue in diffuse large-cell lymphoma: long-term disease control and toxicity. J Clin Oncol. 2008 Apr 10; 26 (11):1858-64 Epub 2008 Mar 10
    View PubMed
  189. Gomez DR, Hoppe BS, Wolden SL, Zhung JE, Patel SG, Kraus DH, Shah JP, Ghossein RA, Lee NY. Outcomes and prognostic variables in adenoid cystic carcinoma of the head and neck: a recent experience. Int J Radiat Oncol Biol Phys. 2008 Apr 1; 70 (5):1365-72 Epub 2007 Oct 29
    View PubMed
  190. Hoppe BS, Stegman LD, Zelefsky MJ, Rosenzweig KE, Wolden SL, Patel SG, Shah JP, Kraus DH, Lee NY. Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting--the MSKCC experience. Int J Radiat Oncol Biol Phys. 2007 Mar 1; 67 (3):691-702 Epub 2006 Dec 08
    View PubMed
  191. Araujo MI, Hoppe B, Medeiros M Jr, Alcantara L, Almeida MC, Schriefer A, Oliveira RR, Kruschewsky R, Figueiredo JP, Cruz AA, Carvalho EM. Impaired T helper 2 response to aeroallergen in helminth-infected patients with asthma. J Infect Dis. 2004 Nov 15; 190 (10):1797-803 Epub 2004 Oct 12
    View PubMed
  192. Prasad M, Ben-Porat L, Hoppe B, Aghajanian C, Sabbatini P, Chi DS, Hensley ML. Costs of treatment and outcomes associated with second-line therapy and greater for relapsed ovarian cancer. Gynecol Oncol. 2004 Apr; 93 (1):223-8
    View PubMed
  193. Araujo MI, Hoppe BS, Medeiros M Jr, Carvalho EM. Schistosoma mansoni infection modulates the immune response against allergic and auto-immune diseases. Mem Inst Oswaldo Cruz. 2004; 99 (5 Suppl 1):27-32 Epub 2004 Oct 13
    View PubMed
  194. Hensley ML, Hoppe B, Leon L, Sabbatini P, Aghajanian C, Chi D, Spriggs DR. The costs and efficacy of liposomal doxorubicin in platinum-refractory ovarian cancer in heavily pretreated patients. Gynecol Oncol. 2001 Sep; 82 (3):464-9
    View PubMed
  195. Hoppe BS, Jensen RB, Kirchgessner CU. Complementation of the Radiosensitive MO59J Cell Line Radiation Research. 2000; 153(2):125-130.
    View PubMed
PST-20471600